Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Prediction of repeatable glaucomatous visual field defects based on cluster characteristics

Jeremy C.K. TAN; Jack Phu; Giovanni Montesano; Katharina Bell; Ashish Agar; Jonathan Guy Crowston

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5842.

Glaucoma June 2025

The Association of Muscle-Related Factors With Glaucoma and Related Traits in a Large United Kingdom Population

PDF

Kian M. Madjedi; Kelsey V. Stuart; Grace S. Yin; Robert N. Luben; Zihan Sun; Mahantesh Biradar; Ruiqi Hu; Paul J. Foster; Peng T. Khaw; Katharina C. Bell; Jonathan G. Crowston; Anthony P. Khawaja; on behalf of the UK Biobank Eye and Vision Consortium
TAGS: glaucoma, muscle, intraocular pressure
Invest. Ophthalmol. Vis. Sci.. 2025; 66(6):66. https://doi.org/10.1167/iovs.66.6.66

Glaucoma July 2022

Crystallins Play a Crucial Role in Glaucoma and Promote Neuronal Cell Survival in an In Vitro Model Through Modulating Müller Cell Secretion

PDF

Hanhan Liu; Katharina Bell; Anja Herrmann; Stefan Arnhold; Karl Mercieca; Fabian Anders; Kerstin Nagel-Wolfrum; Solon Thanos; Verena Prokosch
TAGS: crystallins, glaucoma, alpha-crystallin b chain
Invest. Ophthalmol. Vis. Sci.. 2022; 63(8):3. https://doi.org/10.1167/iovs.63.8.3

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Age related RGC vulnerability in an autophagy deficient mouse model

Katharina Bell; Ines Rosignol; elena Sierra-Filardi; Carsten Schmelter; Franz H Grus; Patricia Boya

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2360.

ARVO Annual Meeting Abstract July 2018

Fc Receptors involved in neuroprotective γ- Synuclein antibody transport into retinal Müller cells

Katharina Bell; Corina Wilding; Ines Rosignol; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6143.

ARVO Annual Meeting Abstract June 2017

Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy

Katrin Lorenz; Joanna Wasielica-Poslednik; Katharina Bell; Guilia Renieri; Alexander Keicher; Christian Ruckes; Norbert Pfeiffer; Hagen Thieme

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2103.

ARVO Annual Meeting Abstract June 2017

Neuroprotective antibodies trigger CNTF secretion of Müller cells

Katharina Bell; Corina Wilding; Sabine Beck; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2552.

ARVO Annual Meeting Abstract June 2017

Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

Bogomil Voykov; Hagen Thieme; Katharina Bell; Melanie Weigel; Guilia Renieri; Barbara Wilhelm; Katrin Lorenz; Petra Fettes; Eugen Leo; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5577.

ARVO Annual Meeting Abstract September 2016

Glutamine synthetase shift involved in protective effects of GFAP antibody on retinal ganglion cells

Katharina Bell; Corina Wilding; Jana Holz-Müller; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2567.

ARVO Annual Meeting Abstract September 2016

Protein changes within the Rho pathway in neuroretinal cells after incubation with POAG serum: Cofilin, Rac1, CDC42 – causes for the effect of ROCK-inhibitors?

Madeleine Kiderle; Katharina Bell; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5635.

ARVO Annual Meeting Abstract September 2016

Mass spectrometric analysis of novel antibody-peptide sequences in glaucoma.

Carsten Schmelter; Natarajan Perumal; Sebastian Funke; Katharina Bell; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6018.

ARVO Annual Meeting Abstract June 2015

Gamma- synuclein antibodies have protective effect on retinal ganglion cells

Katharina Bell; Corina Wilding; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3667.

ARVO Annual Meeting Abstract April 2014

Participation of ERP57 in the pro-survival potential of GFAP abs on RGC5

Corina Wilding; Katharina Bell; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2438.

ARVO Annual Meeting Abstract April 2014

Changed levels of CD4(+)CD25(+) T cells in glaucoma patients in comparison to healthy controls

Katharina Bell; Anna Holz; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5709.

ARVO Annual Meeting Abstract June 2013

Changes in antibodies from glaucoma patients lead to changes in apoptosis pathways of neuroretinal cells

Katharina Bell; Corina Wilding; Sebastian Funke; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1605.

ARVO Annual Meeting Abstract June 2013

Protective effect of GFAP antibody on RGC5 cells via actin cytoskeleton pathways

Corina Wilding; Katharina Bell; Sebastian Funke; Sabine Beck; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):432.

ARVO Annual Meeting Abstract June 2013

In Depth Analysis of Retinal Proteins using a Combinatory HPLC based Mass Spectrometric Platform

Sebastian Funke; Dominik Wolters; Lukas Weiler; Francis Mwiiri; Katharina Bell; Corina Wilding; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):698.

ARVO Annual Meeting Abstract March 2012

Effect Of - Synuclein Antibody On Rgc5 And Mitochondrial Apoptosis Pathways

Corina Wilding; Katharina Bell; Franz Grus; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6591.

ARVO Annual Meeting Abstract March 2012

Down Regulation Of 14-3-3 Ab In Glaucoma Patients Could Lead To Loss Of Protective Effects

Katharina Bell; Corina Wilding; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6592.

ARVO Annual Meeting Abstract April 2011

Protective Effect Of - synuclein Antibody On Stressed Retinal Ganglion Cells

Corina Wilding; Katharina Bell; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3939.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Prediction of repeatable glaucomatous visual field defects based on cluster characteristics

The Association of Muscle-Related Factors With Glaucoma and Related Traits in a Large United Kingdom Population

Crystallins Play a Crucial Role in Glaucoma and Promote Neuronal Cell Survival in an In Vitro Model Through Modulating Müller Cell Secretion

Age related RGC vulnerability in an autophagy deficient mouse model

Fc Receptors involved in neuroprotective γ- Synuclein antibody transport into retinal Müller cells

Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy

Neuroprotective antibodies trigger CNTF secretion of Müller cells

Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

Glutamine synthetase shift involved in protective effects of GFAP antibody on retinal ganglion cells

Protein changes within the Rho pathway in neuroretinal cells after incubation with POAG serum: Cofilin, Rac1, CDC42 – causes for the effect of ROCK-inhibitors?

Mass spectrometric analysis of novel antibody-peptide sequences in glaucoma.

Gamma- synuclein antibodies have protective effect on retinal ganglion cells

Participation of ERP57 in the pro-survival potential of GFAP abs on RGC5

Changed levels of CD4(+)CD25(+) T cells in glaucoma patients in comparison to healthy controls

Changes in antibodies from glaucoma patients lead to changes in apoptosis pathways of neuroretinal cells

Protective effect of GFAP antibody on RGC5 cells via actin cytoskeleton pathways

In Depth Analysis of Retinal Proteins using a Combinatory HPLC based Mass Spectrometric Platform

Effect Of - Synuclein Antibody On Rgc5 And Mitochondrial Apoptosis Pathways

Down Regulation Of 14-3-3 Ab In Glaucoma Patients Could Lead To Loss Of Protective Effects

Protective Effect Of - synuclein Antibody On Stressed Retinal Ganglion Cells

To View More...

You must be signed into an individual account to use this feature.